Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
38°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Outlook Therapeutics Inc
(NQ:
OTLK
)
8.500
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
138
Open
8.500
Bid (Size)
8.000 (1)
Ask (Size)
8.750 (1)
Prev. Close
8.500
Today's Range
8.500 - 8.500
52wk Range
0.2002 - 12.85
Shares Outstanding
260,257,517
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
Insiders Buying Outlook Therapeutics And 2 Other Stocks
April 01, 2024
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
Via
Benzinga
Performance
YTD
+2062.30%
+2062.30%
1 Month
-12.37%
-12.37%
3 Month
+2244.83%
+2244.83%
6 Month
+2400.00%
+2400.00%
1 Year
+658.93%
+658.93%
More News
Read More
Gold Moves Lower; Lululemon Shares Plummet
March 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 22, 2024
Via
Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
March 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 of the Best Speculative Stocks You Can Snag for Less Than $1
March 06, 2024
Via
InvestorPlace
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 23, 2024
Via
Benzinga
OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
January 01, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK
January 01, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
December 31, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
December 31, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
December 30, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm
December 29, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
OTLK DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
December 29, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Via
Benzinga
OTLK DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
December 28, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outlook Therapeutics, Inc. (OTLK)
December 28, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
OTLK Stock Earnings: Outlook Therapeutics Reported Results for Q4 2023
December 27, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
